Health Condition 1: B47- Mycetoma
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Drugs for Neglected Diseases Initiative South Asia Pvt Ltd
Drugs for Neglected Diseases Initiative
Eligibility
Inclusion criteria
Inclusion criteria: Any patient given a diagnosis of mycetoma in a medical, radiologic, or laboratory record
Exclusion criteria
Exclusion criteria: Patients with illegible or inaccessible health records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The annual incidence and trends of mycetoma casesTimepoint: Hospitals records From Jan 2014 to Dec 2023. The outcomes will be analysed from data obtained from all patient records at 1. Baseline up to 2. Last Time point of available patient data record available for analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢Demographic & clinical characteristics of patients with mycetoma â?¢Etiology of mycetoma â?¢Clinical management of mycetoma: Diagnosis, Treatment & Outcomes â?¢ Regional & national mapping of mycetoma cases in India & Senegal.Timepoint: Passive case finding will be conducted for mycetoma cases by reviewing health facilityThe outcomes will be analysed from data obtained from all patient records at 1. Baseline up to 2. Last Time point of available patient data record available for analysis records. This is a cross-sectional design as data will be obtained from point observations (i.e. records from health care visits). | — |
Countries
India, Senegal
Contacts
Public ContactDr Shivaprakash M Rudramurthy
Postgraduate Institute of Medical Education and Research
Outcome results
None listed